Real World Implementation of AlcoChange: a SmartPhoen Digital Therapuetic to improve outcome from Alcohol Related Liver Disease.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form.
AlcoChange is the personalised behavioural change therapist in your pocket that observes your behaviours, adapts to your preferences and helps you achieve your abstinence goal.
Deaths from liver disease are increasing at an alarming rate, primarily associated with increasing alcohol consumption. Urgent action is now required to deal with this increasing problem. The current approach is associated with Alcohol Care Teams engaging with individuals to provide counselling, psychological appraisal and, where possible, drug therapy. However, this requires an alternative or additional approach with increasing numbers of individuals presenting with alcohol-related liver conditions..
CyberLiver addresses this urgent clinical need through an innovative AlcoChange - a novel, patented, CE-marked digital therapeutic based on a smartphone app and breathalyser, developed with feedback from alcohol service users and validated in a pilot study in a clinical setting in the UK. AlcoChange allows self-monitoring of craving, alcohol use/abstinence and breath alcohol and provides motivational messaging in response to patient triggers.
AlcoChange (a smartphone app with an optional breathalyser) can help patients with Alcohol-related Liver Disease (ARLD) abstain from, or reduce, alcohol use.
AlcoChange is proven to help people reduce alcohol consumption and work towards abstinence, which is essential in improving liver health
AlcoChange is a patented groundbreaking Digital Therapeutic solution that is designed to help users abstain from or reduce alcohol consumption
AlcoChange was created based on an amalgamation of various behavioural change techniques
AlcoChange brings the science of behaviour change to you by utilising a unique combination of various behavioural change techniques through a patented CyberLiver Behavioural Change methodology.
Behavioural interventions are personalised and ever-evolving to adapt to the user’s needs
Encourages engagement and participation through regular motivations, nudges and follow-ups
Learn how to identify triggers, break negative behaviours, and develop healthier responses
AlcoChange® intended to reduce alcohol use and maintain abstinence in individuals with established alcohol-related liver disease.
AlcoChange is proven to help people reduce alcohol consumption and work towards abstinence, which is essential in improving liver health.
AlcoChange is a patented groundbreaking Digital Therapeutic solution that is designed to help users abstain from or reduce alcohol consumption.
If you want to improve your liver health outcome, please check with your healthcare provider whether they offer the AlcoChange prescription therapy. AlcoChange therapy is currently been provided only via your Healthcare provider.
f you are a healthcare provider and would like to partner with us for a clinical trial, please email info@cyberliver.com.
AlcoChange is a 90 day prescription digital therapeutic.
AlcoChange comes included with the AlcoChange patient app and an optional Digital Breathalyser.
As part of the enrolment and onboarding, you will be guided using the AlcoChange application and breathalyser.
As part of the AlcoChange clinician setup, you will have access to patient details and real-time patient monitoring using an actionable clinician dashboard.
Please contact our support team at help@cyberliver.com if you have any technical issues with the AlcoChange app or breathalyser.
Whether you are a healthcare provider, a clinical trial partner, an ARLD patient or a user who wants to reduce your alcohol consumption and gain access to AlcoChange or support along your journey, we are here to help.
If you are an already existing customer or have technical or other issues, our experts are ready to help.